Celcuity Inc. (CELC) stock
CELCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$55.60−2.41 (-4.15%)
Close on Nov 18, 2026Market cap $2.72BP/E –Yield –
Celcuity free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Celcuity's free cash flow for the twelve months ending Jun 30, 2026 was -$192.16M. For fiscal 2025 it was -$153.53M. The highest annual figure on record is -$2.93M in fiscal 2016.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$153.53M | – |
| FY2024 | Dec 31, 2024 | -$83.72M | – |
| FY2023 | Dec 31, 2023 | -$53.91M | – |
| FY2022 | Dec 31, 2022 | -$36.17M | – |
| FY2021 | Dec 31, 2021 | -$20.39M | – |
| FY2020 | Dec 31, 2020 | -$7.24M | – |
| FY2019 | Dec 31, 2019 | -$5.62M | – |
| FY2018 | Dec 31, 2018 | -$6.71M | – |
| FY2017 | Dec 31, 2017 | -$5.19M | – |
| FY2016 | Dec 31, 2016 | -$2.93M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$55.48M | – |
| Q1 FY2026 | Mar 31, 2026 | -$55.31M | – |
| Q4 FY2025 | Dec 31, 2025 | -$36.45M | – |
| Q3 FY2025 | Sep 30, 2025 | -$44.91M | – |
| Q2 FY2025 | Jun 30, 2025 | -$36.25M | – |
| Q1 FY2025 | Mar 31, 2025 | -$35.91M | – |
| Q4 FY2024 | Dec 31, 2024 | -$27.82M | – |
| Q3 FY2024 | Sep 30, 2024 | -$20.61M | – |
| Q2 FY2024 | Jun 30, 2024 | -$18.13M | – |
| Q1 FY2024 | Mar 31, 2024 | -$17.16M | – |
| Q4 FY2023 | Dec 31, 2023 | -$18.57M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.80M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.67M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.87M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.59M | – |
| Q3 FY2022 | Sep 30, 2022 | -$9.32M | – |
| Q2 FY2022 | Jun 30, 2022 | -$11.31M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.94M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.13M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.06M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.64M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.55M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.12M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.66M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.58M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.88M | – |
| Q4 FY2019 | Dec 31, 2019 | -$971.07K | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.01M | – |
| Q2 FY2019 | Jun 30, 2019 | -$995.45K | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.64M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.67M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.88M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.50M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.65M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.15M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.67M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.42M | – |
| Q1 FY2017 | Mar 31, 2017 | -$957.52K | – |
| Q4 FY2016 | Dec 31, 2016 | -$714.13K | – |
See a number that looks wrong?